Resources / NITAG documentation

Updated guidance to protect infants and children from respiratory syncytial virus (RSV) disease: use of monoclonal antibodies (nirsevimab and clesrovimab) and the RSVpreF vaccine

Download:
Abstract

NACI updated their guidance for use of monoclonal antibodies (nirsevimab and clesrovimab) and the RSVpreF vaccine for infants and children.

Americas Canada children infants RSV (Respiratory syncytial virus)
Loading...